| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Common Stock | 14,366 | $1,019,698 | $70.98 | 20 Feb 2026 | Direct |
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Performance Stock Units | 14,751 | 09 Feb 2026 | Direct | ||
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Option to Purchase Common Stock | 14,047 | 09 Feb 2026 | Direct | ||
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Restricted Stock Units | 7,998 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | 20 Feb 2026 | 3 | -$73,606 | 4 | SVP, CHIEF OPERATING OFFICER | 24 Feb 2026, 18:19 |
| HALO | HALOZYME THERAPEUTICS, INC. | 09 Feb 2026 | 4 | $0 | 4 | SVP, CHIEF OPERATING OFFICER | 11 Feb 2026, 21:21 |
| HALO | HALOZYME THERAPEUTICS, INC. | 01 Nov 2025 | 3 | -$277,905 | 4 | SVP, CHIEF OPERATING OFFICER | 19 Dec 2025, 17:39 |
| HALO | HALOZYME THERAPEUTICS, INC. | 03 Oct 2025 | 2 | $0 | 4 | SVP, CHIEF OPERATING OFFICER | 06 Oct 2025, 17:18 |
| HALO | HALOZYME THERAPEUTICS, INC. | 01 Oct 2025 | 0 | $0 | 3 | SVP, CHIEF OPERATING OFFICER | 06 Oct 2025, 17:14 |